论文部分内容阅读
最近作者报道,鼻咽癌患者(SR)在使用人β干扰素(HuIFN-β)治疗奏效后,出现HuIFN-β中和抗体。本文探讨了这种异常抗体出现的原因。SR 患者在用干扰素治疗10个月后停药,6个月后从患者取得一块皮肤组织进行连续
Recent authors report that HuIFN-β neutralizing antibodies appear in patients with nasopharyngeal carcinoma (SR) after treatment with human interferon-beta (HuIFN-β). This article explores the causes of this abnormal antibody. Patients with SR were discontinued 10 months after treatment with interferon, and a piece of skin tissue was obtained from the patient 6 months later for continuous